A detailed history of Northern Trust Corp transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 497,304 shares of RGLS stock, worth $815,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
497,304
Previous 172,750 187.87%
Holding current value
$815,578
Previous $309,000 152.43%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.46 - $1.9 $473,848 - $616,652
324,554 Added 187.87%
497,304 $780,000
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.8 $277,041 - $433,361
154,772 Added 860.9%
172,750 $309,000
Q3 2022

Nov 14, 2022

SELL
$1.35 - $2.39 $4 - $7
-3 Reduced 0.02%
17,978 $31,000
Q2 2022

Aug 12, 2022

BUY
$1.6 - $3.4 $28,769 - $61,135
17,981 New
17,981 $37,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $24M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.